<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Royal (Dick) School of Veterinary Scienc</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/71BBD3D8-65FD-4B29-BF3D-CA86446E12C7"><gtr:id>71BBD3D8-65FD-4B29-BF3D-CA86446E12C7</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Brophy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0000221"><gtr:id>C4E77D57-7301-4679-A5BF-CC810C63054A</gtr:id><gtr:title>Functional genomics of axon-glial interactions in the CNS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0000221</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>600033</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MS Network, Local MS groups</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DD2D6679-EC4F-4AC9-9A81-B055408EAC84</gtr:id><gtr:impact>The patients and professionals were more informed about MS research.

Reinvitations.</gtr:impact><gtr:outcomeId>G9QinXe8hDh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>22175154-C914-431A-8409-1FE0F3E71F11</gtr:id><gtr:title>A novel 4.1 ezrin radixin moesin (FERM)-containing protein, 'Willin'.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aeae27b6f75d4cc5a995c435d3009b9"><gtr:id>9aeae27b6f75d4cc5a995c435d3009b9</gtr:id><gtr:otherNames>Gunn-Moore FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>MTZ7fXdXvNi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>189E5AEB-1FE2-4F66-9177-256909522CCD</gtr:id><gtr:title>Mechanisms of axon ensheathment and myelin growth.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05c2278fefa57da5cc7af6a34321b5d1"><gtr:id>05c2278fefa57da5cc7af6a34321b5d1</gtr:id><gtr:otherNames>Sherman DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>WaynSDtRCp6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FFB7C24-9EF7-4219-B750-FA506288819F</gtr:id><gtr:title>Neurofascins are required to establish axonal domains for saltatory conduction.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05c2278fefa57da5cc7af6a34321b5d1"><gtr:id>05c2278fefa57da5cc7af6a34321b5d1</gtr:id><gtr:otherNames>Sherman DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>a5jUPwCVHMj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D47ADDF-05C7-47DA-9137-51270B9E0151</gtr:id><gtr:title>Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f455425a62021d7ec9ff3bfef06c24d2"><gtr:id>f455425a62021d7ec9ff3bfef06c24d2</gtr:id><gtr:otherNames>Charles P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_14049_19_11839274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43DFE71-F135-4570-BB6E-CD999FF5979D</gtr:id><gtr:title>Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de6f3ef5361e4a27c73aab4aad7e4eb"><gtr:id>2de6f3ef5361e4a27c73aab4aad7e4eb</gtr:id><gtr:otherNames>Howell OW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14049_19_17041241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C13BE0F8-EC26-4CBC-96E3-E4438A43FA89</gtr:id><gtr:title>Genetic dysmyelination alters the molecular architecture of the nodal region.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dba6d18327678e83beea8b198dacd788"><gtr:id>dba6d18327678e83beea8b198dacd788</gtr:id><gtr:otherNames>Arroyo EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_14049_19_11880502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F71C7C1-72DB-4358-8E36-D773D2346F0F</gtr:id><gtr:title>A functional FERM domain binding motif in neurofascin.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aeae27b6f75d4cc5a995c435d3009b9"><gtr:id>9aeae27b6f75d4cc5a995c435d3009b9</gtr:id><gtr:otherNames>Gunn-Moore FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>pm_14049_19_17045809</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0000221</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>